Correction

V Jelic, M Kivipelto, B Winblad. Clinical trials in mild cognitive impairment: lessons for the future (J Neurol Neurosurg Psychiatry 2006;77:429–38).

In table 1 the column with heading Galantamine study 1 (GAL‐INT‐11) and row with heading ApoE e4, 26.4% galantamine, 29.5% placebo should be 45% galantamine, 47% placebo.

In table 1 the column with heading Galantamine study 2 (GAL‐INT‐18) and row with heading ApoE e4 24.4% galantamine, 23.5% placebo should be 42% galantamine, 41% placebo.